Friday, September 30, 2011
Thursday, September 29, 2011
Monday, September 26, 2011
Friday, September 23, 2011
Monday, September 19, 2011
Thursday, September 15, 2011
Sunday, September 11, 2011
Wednesday, September 7, 2011
A PICC is a long, slender, small, flexible tube that is inserted into a peripheral vein, typically in the upper arm, and advanced until the catheter tip terminates in a large vein in the chest near the heart to obtain intravenous access. It is similar to other central lines as it terminates into a large vessel near the heart. However, unlike other central lines, its point of entry is from the periphery of the body the extremities. And typically the upper arm is the area of choice.
A PICC line provides the best of both worlds concerning venous access. Similar to a standard IV, it is inserted in the arm, and usually in the upper arm under the benefits of ultrasound visualization. Also, PICCs differ from peripheral IV access but similar to central lines in that a PICCs termination point is centrally located in the body allowing for treatment that could not be obtained from standard periphery IV access. In addition, PICC insertions are less invasive, have decreased complication risk associated with them, and remain for a much longer duration than other central or periphery access devices.
Using ultrasound technology to visualize a deep, large vessel in the upper arm, the PICC catheter is inserted by a specially trained and certified PICC nurse specialist. Post insertion at the bedside, a chest x-ray is obtained to confirm ideal placement.http://picclinenursing.com/picc_why.html
And here's a picture of where the PICC goes
Monday, September 5, 2011
While I understand the challenges you face in reducing the deficit and balancing the budget, cystic fibrosis patients need your help to ensure that NIH can fund research that can produce new treatments, and the FDA can swiftly and thoroughly review them. These critical agencies must be able to move new therapies quickly from bench to bedside.
Drew looks healthy on the outside, but he is fighting a progressive and fatal disease. Everyday, Drew spends between 2 and 3 hours doing airway clearance and breathing treatments to keep his lungs healthy and clear of mucus. We have cabinets full of medication that Drew must take on a daily basis. The best part about Drew is that he does it all with a smile on his face. We are learning more every day, and, through Drew, we've discovered a new world of support, education, and opportunity for those living with Cystic Fibrosis. Unfortunately, it does not change the fact that there is currently no cure. We can change that!
This year has been an amazing one for the entire CF community. The money that WE have raised over the past many years helped to develop the first drug to target the basic defect of Cystic Fibrosis. That drug, VX-770, will be going to the FDA for approval late this year. I can only imagine how different our lives will be with this drug and the others in the pipeline. I can only imagine my baby healthy, without Cystic Fibrosis. We are so close to a cure. It's almost here, but we still need your help.
Strong, sustained NIH funding is essential to national priorities of better health and economic vitalization.These important agencies contribute to the nation's economic strength by creating skilled, high-paying jobs. In 2007, NIH grants and contracts created and supported more than 350,000 jobs across the United States. A well-funded FDA can help ensure promising research is translated into new cures and reduce the cost of health care on the American economy and for American families.Once again I urge you to actively support robust funding for NIH and FDA in Fiscal Years 2011 and 2012 and help us create better tomorrows for those with cystic fibrosis and all rare diseases.Thank you again for your time!